Multi-national, Safety and Performance Study of New Ostomy Product Compared to Standard Care
Primary Purpose
Leakage, Skin Condition
Status
Terminated
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
New ostomy base plate (SS)
Standard Care base plate
Sponsored by
About this trial
This is an interventional treatment trial for Leakage
Eligibility Criteria
Inclusion Criteria:
- Have given written Informed Consent
- Is at least 18 years old
- Has the mental capacity to understand the study guidelines and questionnaires
- Has had their ileostomy for at least 3 months
- Has an ileostomy with a diameter between 19-40 mm
- Is currently using a flat 2-piece product with with mechanical coupling
- Is able to change the base plate by themselves or with help from a caregiver (e.g. spouse)
- Has experienced leakage under the base plate at least once a week over the last 2 weeks
Exclusion Criteria:
- Is pregnant or breast-feeding
- Currently receiving or has within the past 2 months received radio- and/or chemotherapy
- Currently using topical steroid product on peristomal skin (injections and oral treatment are accepted)
- Is currently using a convex base plate
- Participating in other clinical studies or has previously participated in this study
Sites / Locations
- Sygehus Sønderjylland i Aabenraa
- Bispebjerg Hospital
- Hvidovre Hospital
- Odense Universitetshospital
- Hôpital Nord
- Hôpital Hôtel Dieu de Nantes
- Hôpital Lariboisière
- CHRU La Milétrie
- Hôpital de Pontchaillou, CHRU de Rennes
- Sanitätshaus Fürst GmbH
- Landspitali University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Standard Care base plate
New ostomy base plate (SS)
Arm Description
Standard care are the participants own product and can have several manufacture and brand names
SS = New ostomy base plate. Due to company confidentiality the product is called SS and this is not short for any name
Outcomes
Primary Outcome Measures
Degree of Output Under the Base Plate (Leakage).
Degree of output is measured by a 24-point leakage assessment scale (0 indicating no leakage and 24 indicating maximum leakage).
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01517178
Brief Title
Multi-national, Safety and Performance Study of New Ostomy Product Compared to Standard Care
Official Title
An Open-labelled, Randomised, Controlled, Comparative, Multi-national, Cross-over Study Investigating the Safety and Performance of a New 2-piece Ostomy Product Compared to 2-piece Standard Care Ostomy Products
Study Type
Interventional
2. Study Status
Record Verification Date
March 2015
Overall Recruitment Status
Terminated
Study Start Date
May 2011 (undefined)
Primary Completion Date
June 2011 (Actual)
Study Completion Date
June 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Coloplast A/S
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary object of this study is to provide clinical documentation for the New base plate significantly 'reduces the degree of Leakage' under the base plate compared to Standard Care base plates.
The secondary objectives are to provide clinical documentation on several performance and safety parameters on the New base plate compared to Standard Care base plates.
The primary hypothesis is that the New base plate significantly reduces degree of leakage under the base plate compared to Standard Care base plates.
Each test period will last for two weeks. In addition to this there will be one week run-in period on New base plate. The data will be collected by investigator in the Case Report Form at the inclusion visit, cross-over visit and termination visit. Data will also be collected by the subject in a questionnaire during the two test periods.
The subjects will change their base plates on per need basis and continue with their normal changing pattern in the entire study period.
100 subjects with ileostomy will be included in the study. The subjects will be recruited from Europe including Denmark, Norway, Sweden, Iceland, Germany and France.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Leakage, Skin Condition
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
33 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Standard Care base plate
Arm Type
Active Comparator
Arm Description
Standard care are the participants own product and can have several manufacture and brand names
Arm Title
New ostomy base plate (SS)
Arm Type
Experimental
Arm Description
SS = New ostomy base plate. Due to company confidentiality the product is called SS and this is not short for any name
Intervention Type
Device
Intervention Name(s)
New ostomy base plate (SS)
Intervention Description
The base plate is applied to the skin around the stoma and an ostomy bag is clicked onto the base plate.
Intervention Type
Device
Intervention Name(s)
Standard Care base plate
Intervention Description
The base plate is applied to the skin around the stoma and an ostomy bag is clicked onto the base plate.
Primary Outcome Measure Information:
Title
Degree of Output Under the Base Plate (Leakage).
Description
Degree of output is measured by a 24-point leakage assessment scale (0 indicating no leakage and 24 indicating maximum leakage).
Time Frame
Each test product was assessed for 2 weeks.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Have given written Informed Consent
Is at least 18 years old
Has the mental capacity to understand the study guidelines and questionnaires
Has had their ileostomy for at least 3 months
Has an ileostomy with a diameter between 19-40 mm
Is currently using a flat 2-piece product with with mechanical coupling
Is able to change the base plate by themselves or with help from a caregiver (e.g. spouse)
Has experienced leakage under the base plate at least once a week over the last 2 weeks
Exclusion Criteria:
Is pregnant or breast-feeding
Currently receiving or has within the past 2 months received radio- and/or chemotherapy
Currently using topical steroid product on peristomal skin (injections and oral treatment are accepted)
Is currently using a convex base plate
Participating in other clinical studies or has previously participated in this study
Facility Information:
Facility Name
Sygehus Sønderjylland i Aabenraa
City
Aabenraa
ZIP/Postal Code
6200
Country
Denmark
Facility Name
Bispebjerg Hospital
City
Copenhagen
ZIP/Postal Code
2400
Country
Denmark
Facility Name
Hvidovre Hospital
City
Hvidovre
ZIP/Postal Code
2650
Country
Denmark
Facility Name
Odense Universitetshospital
City
Odense
ZIP/Postal Code
5000
Country
Denmark
Facility Name
Hôpital Nord
City
Marseille
ZIP/Postal Code
13015
Country
France
Facility Name
Hôpital Hôtel Dieu de Nantes
City
Nantes cedex 1
ZIP/Postal Code
44093
Country
France
Facility Name
Hôpital Lariboisière
City
Paris cedex 10
ZIP/Postal Code
75475
Country
France
Facility Name
CHRU La Milétrie
City
Poitiers cedex
ZIP/Postal Code
86021
Country
France
Facility Name
Hôpital de Pontchaillou, CHRU de Rennes
City
Rennes cedex 9
ZIP/Postal Code
35033
Country
France
Facility Name
Sanitätshaus Fürst GmbH
City
Passau
ZIP/Postal Code
94032
Country
Germany
Facility Name
Landspitali University Hospital
City
Reykjavik
ZIP/Postal Code
108
Country
Iceland
12. IPD Sharing Statement
Learn more about this trial
Multi-national, Safety and Performance Study of New Ostomy Product Compared to Standard Care
We'll reach out to this number within 24 hrs